64th ISI World Statistics Congress - Ottawa, Canada

64th ISI World Statistics Congress - Ottawa, Canada

Building statistical capacity for clinical trials in Sub-Saharan Africa

Organiser

LT
Dr Lehana Thabane

Participants

  • LT
    Dr Lehana Thabane
    (Chair)

  • RM
    Rhoderick Macheckano
    (Presenter/Speaker)
  • Experiences from building a biostatistics graduate program at Stellenbosch University

  • SM
    Prof. Samuel Manda
    (Presenter/Speaker)
  • Discussant

  • TC
    Prof. Tobias Chirwa
    (Presenter/Speaker)
  • The Sub-Saharan African Consortium for Advanced Biostatistics (SSACAB) training programme

  • MG
    Dr Misrak Gezmu
    (Presenter/Speaker)
  • South-North Clinical Trial collaborations: Strengthening local biostatistics capacity in sub-Saharan African countries

  • TE
    Tonya Esterhuizen
    (Discussant)

  • Category: International Statistical Institute

    Abstract

    Sub-Saharan Africa has a critical shortage of well-trained clinical research methodologists, in particular, biostatisticians and clinical trial methodologists. Supported by the and Welcome Trust and the Fogarty International Heath NIH grants, respectively, the Sub-Saharan Africa Consortium for Advanced Biostatistics Training (SSACAB) and the Stellenbosch MSc in Biostatistics Program, were designed to:
    1. Develop, strengthen and implement high quality biostatistics graduate training;
    2. Develop expertise, skills, and research leaders of biostatistics in Sub-Saharan Africa;
    3. Build a sustainable network of biostatisticians and statistically informed researchers through outreach, and mentoring; and
    4. Integrate with International Biostatistics Societies and National Statistical Societies to produce a cadre of internationally trained African biostatisticians.
    This has been a partnership among several universities in the region and in the North, and national and international funding agencies. The objective of this session is to share experiences about how these endeavors were approached, the successes and challenges todate, the lessons learnt, and the funders’ perspectives, about how to build capacity in clinical trial methodology in resource-stricken settings.